ENCRPC 40MG contain enzalutamide which belongs to a group of medicine called androgen receptor inhibitors. It is used to treat adult men with prostate cancer that no longer responds to a hormone therapy or surgical treatment to lower testosterone (or) has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone.
Prostate cancer is marked by an uncontrolled (malignant) growth of cells in the prostate gland. The prostate is the walnut-sized gland in men, located just below the bladder and in front of the rectum, surrounding the urethra which is the tube that carries urine out of the bladder. It is also called as prostatic carcinoma.
The most common side effects are tiredness, hot flushes, high blood pressure. ENCRPC 40MG works by blocking the activity of hormones called androgens (such as testosterone). By blocking androgens, enzalutamide stops prostate cancer cells from growing and dividing. This medicine may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.
This medicine is strictly not recommended for use in children and adolescents. Before taking this medicine tell your doctor if you have ever had kidney disease, heart disease, liver problems.